Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individual 6MP Dose Increments in Childhood ALL
NCT00548431Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of mercaptopurine in acute lymphoblastic leukemia (ALL), sponsored by Rigshospitalet. Started Dec 2007; status: completed.
02
Drugs
mercaptopurine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00548431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548431.